|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4045 | |
| A61K 31/519 |
| (11) | Patento numeris | 2720696 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12730099.4 |
| Europos patento paraiškos padavimo data | 2012-06-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-04-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-05-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/042174 |
| Data | 2012-06-13 |
| (87) | Numeris | WO 2012/174061 |
| Data | 2012-12-20 |
| (30) | Numeris | Data | Šalis |
| 201161496750 P | 2011-06-14 | US | |
| 201161568717 P | 2011-12-09 | US |
| (72) |
BAFFERT, Fabienne, CH
RADIMERSKI, Thomas, CH
GADBAW, Brian, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | COMBINATION OF PANOBINOSTAT AND RUXOLITINIB IN THE TREATMENT OF CANCER SUCH AS A MYELOPROLIFERATIVE NEOPLASM |
| COMBINATION OF PANOBINOSTAT AND RUXOLITINIB IN THE TREATMENT OF CANCER SUCH AS A MYELOPROLIFERATIVE NEOPLASM |